文献速递创伤与烧伤心脑血管急症

动脉损伤修复术中全身抗凝对通畅性与出血的影响

Systemic intraoperative anticoagulation during arterial injury repair: Implications for patency and bleeding.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论多中心回顾性队列显示,动脉损伤修复术中使用全身肝素化抗凝与更高的动脉通畅率相关(93% vs 85%),且未增加因出血重返手术室的风险。

该多中心回顾性队列纳入2005至2013年三家一级创伤中心323例需手术修复的颈部、躯干及近端肢体主要动脉损伤患者,比较术中使用与不使用全身抗凝者的结局。使用全身抗凝组154例,未使用组169例;两组年龄、性别、受伤机制、入院心率及合并伤无差异。全身抗凝组动脉通畅率高于未使用组(93% vs 85%,p=0.02),因出血重返手术室比例无差异(4% vs 6%,p=0.29)。多因素回归校正性别、入院血流动力学、ISS、损伤部位及术后抗凝后,全身抗凝组维持通畅的OR为2.6(95%CI 1.1-6.2,p=0.03)。维持通畅者重返手术室更少(9% vs 78%,p<0.001),ICU住院时间更短(中位3 vs 9天,p<0.01),总住院时间更短(中位13 vs 21天,p<0.01)。

要点

  • 在需手术修复的颈部、躯干及近端肢体主要动脉损伤患者中,术中使用全身抗凝组动脉通畅率93%,未使用组85%(p=0.02)。
  • 术中使用全身抗凝未增加因出血重返手术室的比例(4% vs 6%,p=0.29)。
  • 校正性别、入院血流动力学、ISS、损伤部位及术后抗凝后,全身抗凝组维持动脉通畅的OR为2.6(95%CI 1.1-6.2,p=0.03)。
  • 维持动脉通畅者重返手术室比例更低(9% vs 78%,p<0.001),ICU住院时间更短(中位3 vs 9天,p<0.01),总住院时间更短(中位13 vs 21天,p<0.01)。
  • 作者认为全身抗凝可能改善修复后动脉通畅率,其所致出血风险可能被高估。

适用人群与场景

  • 2005至2013年三家一级创伤中心收治的创伤患者,存在颈部、躯干及近端肢体主要动脉损伤并需手术修复。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入323例患者,其中男性88%,枪弹伤69%;使用全身抗凝组154例,未使用组169例。
  • 两组年龄、性别、受伤机制、入院心率及合并伤无差异(均p>0.05)。
  • 全身抗凝组动脉通畅率93%,未使用组85%(p=0.02)。
  • 因出血重返手术室比例:全身抗凝组4%,未使用组6%(p=0.29)。
  • 多因素回归校正性别、入院血流动力学、ISS、损伤部位及术后抗凝后,全身抗凝组维持通畅的OR为2.6(95%CI 1.1-6.2,p=0.03)。
  • 维持动脉通畅者重返手术室比例9%,未维持通畅者78%(p<0.001);ICU住院时间中位3天 vs 9天(p<0.01);总住院时间中位13天 vs 21天(p<0.01)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究;证据等级:治疗/临床管理,level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在需手术修复的颈部、躯干及近端肢体主要动脉损伤患者中,术中使用全身抗凝可能改善动脉通畅率,其所致出血风险可能被高估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The role of systemic intraoperative anticoagulation (SIAC) during surgical repair of major arterial injuries is controversial. Any potential improvement in arterial patency must be weighed against the risk of hemorrhage in these critically injured patients. We hypothesized that SIAC would increase arterial patency without increasing bleeding complications.

METHODS: We conducted a multi-institution, retrospective cohort study of trauma patients with major vascular injury from 2005 to 2013 in three Level I centers. Arterial injuries of the neck, torso, and proximal extremities requiring operative management were included. Our primary endpoint was maintenance of arterial patency during index hospitalization. Complications related to bleeding were assessed. The association between SIAC and arterial patency was evaluated using chi-square, t test, and multiple logistic regression modeling.

RESULTS: Of 323 study patients, most were male (88%) and injured by gunshot wounds (69%). Patients repaired with SIAC (n = 154) were compared to those repaired without SIAC (n = 169). No difference in age, gender, mechanism, admission heart rate, or concomitant injury was detected between the groups (all p > 0.05). SIAC use was associated with greater arterial patency rates (93% vs. 85%, p = 0.02) without increasing return to OR for bleeding (4% vs. 6%, p = 0.29). After controlling for gender, admission hemodynamics, ISS, injury location, and postoperative anticoagulation, multivariable regression determined that SIAC patients were 2.6 times more likely (OR 2.6, 95% CI 1.1-6.2, p = 0.03) to maintain patency. Patients who maintained arterial patency were then less likely to return to the OR (9% vs. 78%, p < 0.001) with shorter intensive care unit (median 3 vs. 9 days, p < 0.01) and hospital length of stay (median 13 vs. 21 days, p < 0.01).

CONCLUSION: Patients who underwent operative repair of arterial injuries utilizing SIAC experienced better arterial patency without additional bleeding complications as compared to those repaired without SIAC. Our data suggest that SIAC may improve arterial patency rates after repair and the attributable bleeding risk of SIAC may be overstated.

LEVEL OF EVIDENCE: Therapeutic/care management, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Maher Z, Frank B, Saillant N, et al. Systemic intraoperative anticoagulation during arterial injury repair: Implications for patency and bleeding. J Trauma Acute Care Surg. 2017. PMID: 28099379. doi:10.1097/TA.0000000000001384

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。